Task order: exploring consumers' perceptions of modified risk tobacco product claims
Active Awarded Last action
- Contract number
- 75F40125F19039
- Awardee
-
Westat, Inc. UEI NVUWAFWQ57S5
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $205,243
Award facts
- Contract value 100% obligated
- $205,243.00 Current and potential, with all options
- Completion date 54% complete
- Current and potential, with all options
- NAICS code
- 541820 Public Relations Agencies
- PSC
- AJ11 General Science And Technology R&D Services; General Science And Technology; Basic Research
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Rockville, MD 20850, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $7,680 | |
| Original award | $197,563 |
About this award
The Food and Drug Administration awarded a $205,243 firm fixed price task order to Westat, Inc. for research exploring consumers' perceptions of modified risk tobacco product claims. The work is scheduled for completion by September 28, 2027, and will be performed in Rockville, Maryland. This task order was issued under the FDA's $70 million Quick Turnaround Social Science Research Services blanket purchase agreement (BPA), a multiple-award vehicle established in December 2025 that enables rapid response to agency needs for social science research support. The award carries no small business set-aside designation.
Westat, a large established professional services firm headquartered in Rockville, Maryland, brings over 60 years of experience delivering research, data collection, statistical analysis, and program evaluation services to federal agencies. The company has extensive prior experience supporting the FDA on survey and focus group initiatives, along with significant expertise in tobacco research through its management of the National Institutes of Health's Population Assessment of Tobacco and Health (PATH) Study valued at $797.8 million. This task order leverages Westat's demonstrated capabilities in consumer perception research and qualitative research methodologies to support the FDA's regulatory oversight of modified risk tobacco products.
Quick answers
Who was awarded contract 75F40125F19039?
75F40125F19039 was awarded to Westat, Inc. by Food and Drug Administration (Department of Health and Human Services) on September 25, 2025.
How much is contract 75F40125F19039 worth?
The government has obligated $205,243 on 75F40125F19039.
Is contract 75F40125F19039 an order under another contract?
Yes. 75F40125F19039 is a BPA call under GS23F0155K-75F40120A00018, a blanket purchase agreement, on Advertising & Integrated Marketing Solutions (AIMS).
Was contract 75F40125F19039 competed?
The extent of competition for 75F40125F19039 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award